25 Einträge gefunden

1. Return of individual genomic research results within the PRAEGNANT multicenter registry study

   1. Huebner, Hanna
   2. Ruebner, Matthias
   3. Kurbacher, Christian
   4. Hadji, Peyman
   5. Hartkopf, Andreas D
   6. Lux, Michael P
   7. Huober, Jens

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients

   1. Tzschaschel, Marie
   2. Friedl, Thomas W P
   3. Schochter, Fabienne
   4. Schütze, Sabine
   5. Polasik, Arkadius
   6. Fehm, Tanja
   7. Pantel, Klaus

   2023 - Forschungsinformationssystem des UKE
3. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

   1. Engler, Tobias
   2. Fasching, Peter A
   3. Lüftner, Diana
   4. Hartkopf, Andreas D
   5. Müller, Volkmar
   6. Kolberg, Hans-Christian
   7. Hadji, Peyman

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

   1. Müller, Volkmar
   2. Hein, Alexander
   3. Hartkopf, Andreas D
   4. Fasching, Peter A
   5. Kolberg, Hans-Christian
   6. Hadji, Peyman
   7. Tesch, Hans

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer

   1. Lüftner, Diana
   2. Hartkopf, Andreas D
   3. Lux, Michael P
   4. Overkamp, Friedrich
   5. Tesch, Hans
   6. Titzmann, Adriana
   7. Pöschke, Patrik

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status

   1. Hein, Alexander
   2. Hartkopf, Andreas D
   3. Emons, Julius
   4. Lux, Michael P
   5. Volz, Bernhard
   6. Taran, Florin-Andrei
   7. Overkamp, Friedrich

   2021 - Forschungsinformationssystem des UKE
7. Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial

   1. Pohl-Rescigno, Esther
   2. Hauke, Jan
   3. Loibl, Sibylle
   4. Möbus, Volker
   5. Denkert, Carsten
   6. Fasching, Peter A
   7. Kayali, Mohamad

   2020 - Forschungsinformationssystem des UKE
8. Update Breast Cancer 2020 Part 4 - Advanced Breast Cancer

   1. Tesch, Hans
   2. Müller, Volkmar
   3. Wöckel, Achim
   4. Ettl, Johannes
   5. Belleville, Erik
   6. Schütz, Florian
   7. Hartkopf, Andreas

   2020 - Forschungsinformationssystem des UKE
9. Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab

   1. Michel, Laura L
   2. Hartkopf, Andreas D
   3. Fasching, Peter A
   4. Kolberg, Hans-Christian
   5. Hadji, Peyman
   6. Tesch, Hans
   7. Häberle, Lothar

   2020 - Forschungsinformationssystem des UKE
10. Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine

    1. Laakmann, Elena
    2. Emons, Julius
    3. Taran, Florin-Andrei
    4. Janni, Wolfgang
    5. Uhrig, Sabrina
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2020 - Forschungsinformationssystem des UKE
11. Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer:Data From the GeparOcto-GBG 84 Trial

    1. Rüger, Alexandra Maria
    2. Schneeweiss, Andreas
    3. Seiler, Sabine
    4. Tesch, Hans
    5. van Mackelenbergh, Marion
    6. Marmé, Frederik
    7. Lübbe, Kristina

    2020 - Forschungsinformationssystem des UKE
12. Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany

    1. Huebner, Hanna
    2. Kurbacher, Christian M
    3. Kuesters, Geoffrey
    4. Hartkopf, Andreas D
    5. Lux, Michael P
    6. Huober, Jens
    7. Volz, Bernhard

    2020 - Forschungsinformationssystem des UKE
13. Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry

    1. Hartkopf, Andreas D
    2. Huober, Jens
    3. Volz, Bernhard
    4. Nabieva, Naiba
    5. Taran, Florin-Andrei
    6. Schwitulla, Judith
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
14. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry

    1. Müller, Volkmar
    2. Nabieva, Naiba
    3. Häberle, Lothar
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas D
    6. Volz, Bernhard
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
15. Update Breast Cancer 2018 (Part 1) - Primary Breast Cancer and Biomarkers

    1. Taran, Florin-Andrei
    2. Schneeweiss, Andreas
    3. Lux, Michael P
    4. Janni, Wolfgang
    5. Hartkopf, Andreas D
    6. Nabieva, Naiba
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
16. Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

    1. Schneeweiss, Andreas
    2. Lux, Michael P
    3. Janni, Wolfgang
    4. Hartkopf, Andreas D
    5. Nabieva, Naiba
    6. Taran, Florin-Andrei
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE
17. Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry

    1. Lux, Michael P
    2. Nabieva, Naiba
    3. Hartkopf, Andreas D
    4. Huober, Jens
    5. Volz, Bernhard
    6. Taran, Florin-Andrei
    7. Overkamp, Friedrich

    2018 - Forschungsinformationssystem des UKE - frei zugänglich
18. Update Breast Cancer 2017 - Implementation of Novel Therapies

    1. Lux, Michael P
    2. Janni, Wolfgang
    3. Hartkopf, Andreas D
    4. Nabieva, Naiba
    5. Taran, Florin-Andrei
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
19. Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry

    1. Wallwiener, Markus
    2. Heindl, Felix
    3. Brucker, Sara Y
    4. Taran, Florin-Andrei
    5. Hartkopf, Andreas
    6. Overkamp, Friedrich
    7. Kolberg, Hans-Christian

    2017 - Forschungsinformationssystem des UKE
20. Prognostic impact of circulating tumor cells for breast cancer patients treated in the neoadjuvant "Geparquattro" trial

    1. Riethdorf, Sabine
    2. Müller, Volkmar
    3. Loibl, Sibylle
    4. Nekljudova, Valentina
    5. Weber, Karsten E
    6. Huober, Jens
    7. Fehm, Tanja

    2017 - Forschungsinformationssystem des UKE